Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/17/1998 | US5837525 Polypeptides |
11/17/1998 | US5837508 Hce3p83 polypeptides and polynucleotides used in the design of protocols for treatment of alzheimer's disease, stroke, cancer, inflammation, arthritis, musculoskeletal disease, heart disease, kidney disease and diagnostic assays for such |
11/17/1998 | US5837502 Helicobacter pylori haemagglutinin protease protein, nucleic acid encoding therefor and antibodies specific thereto |
11/17/1998 | US5837499 Genetic engineering with polypeptides and dna molecules |
11/17/1998 | US5837498 Corpuscles of stannius protein, stanniocalcin |
11/17/1998 | US5837497 DNAs encoding mammalian ZPC and uses thereof |
11/17/1998 | US5837496 Promoting cell attachment to a substrate |
11/17/1998 | US5837493 Human galectins |
11/17/1998 | US5837491 Polynucleotides encoding gelonin sequences |
11/17/1998 | US5837489 Isolated nucleic acid |
11/17/1998 | US5837486 Method for preparing soluble analogues of integrins |
11/17/1998 | US5837478 Cellular adhesion molecules |
11/17/1998 | US5837477 Hybrid; immunomodulatory properties |
11/17/1998 | US5837472 Nucleotide sequences coding for a protein with urease activity |
11/17/1998 | US5837460 Methods of identifying biologically active receptor-binding peptides |
11/17/1998 | US5837458 Methods and compositions for cellular and metabolic engineering |
11/17/1998 | US5837451 Identifying composition which affect kinase activity |
11/17/1998 | US5837293 Septic or toxic shock treatment |
11/17/1998 | US5837268 Immunogens; genetic engineering; noncytotoxic; antitumor agents for breast cancer |
11/17/1998 | US5837263 Useful for inducing an immune response to pathogenic leptospira as well as providing a diagnostic target for leptospirosis |
11/17/1998 | US5837262 Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque |
11/17/1998 | US5837244 Treating a cell proliferative disorder |
11/17/1998 | US5837243 Therapeutic compounds comprised of anti-Fc receptor antibodies |
11/17/1998 | US5837242 Multivalent and multispecific binding proteins, their manufacture and use |
11/17/1998 | US5837241 Method of treating heart failure using leukemia inhibitory factor antagonists optionally with endothelin antagonists |
11/17/1998 | US5837239 Wound healing |
11/17/1998 | US5837232 Use of an interleukin-10 antagonist to treat a B cell mediated autoimmune disorder |
11/13/1998 | CA2230971A1 G-protein coupled receptor (hofnh30) |
11/12/1998 | WO1998050567A1 Reagents and methods useful for detecting diseases of the prostate |
11/12/1998 | WO1998050560A1 Human prohormone convertase 4 |
11/12/1998 | WO1998050555A2 Enterococcus faecalis polynucleotides and polypeptides |
11/12/1998 | WO1998050554A2 Enterococcus faecalis polynucleotides and polypeptides |
11/12/1998 | WO1998050552A1 Novel tumor antigens |
11/12/1998 | WO1998050549A2 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr |
11/12/1998 | WO1998050547A2 Human toll-like receptor proteins, related reagents and methods |
11/12/1998 | WO1998050528A1 Isolated nucleic acid molecules encoding ssx family members and uses thereof |
11/12/1998 | WO1998050435A1 Immunotoxins, comprising an onc protein, directed against malignant cells |
11/12/1998 | WO1998050434A1 Methods for eosinophil depletion and compositions therefor |
11/12/1998 | WO1998050433A2 Human monoclonal antibodies to epidermal growth factor receptor |
11/12/1998 | WO1998050432A1 Recombinant antibody-enzyme fusion proteins |
11/12/1998 | WO1998050431A2 A method for making multispecific antibodies having heteromultimeric and common components |
11/12/1998 | WO1998050429A1 Protein smi on hematopoietic stem cells |
11/12/1998 | WO1998050426A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
11/12/1998 | WO1998050424A2 Human serine protease precursor |
11/12/1998 | WO1998050073A1 Integrin ligand, human mindin |
11/12/1998 | WO1998050072A1 Agent for treating tumoral diseases by removing b-lymphocytes from patients |
11/12/1998 | WO1998050021A1 Inhibition of lfa-1/icam-2 dependent leukemic cell aggregation |
11/12/1998 | WO1998036074A3 Single and double chain antibodies to the egf receptor, derivates thereof and their use |
11/12/1998 | WO1998036061A3 Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity |
11/12/1998 | WO1998032864A3 Novel lipid kinase |
11/12/1998 | WO1998031806A3 Fc receptors and polypeptides |
11/12/1998 | WO1998030694A3 TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) |
11/12/1998 | CA2703181A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
11/12/1998 | CA2289727A1 Protein smi on hematopoietic stem cells |
11/12/1998 | CA2289118A1 Novel tumor antigens |
11/12/1998 | CA2289116A1 Enterococcus faecalis polynucleotides and polypeptides |
11/12/1998 | CA2289115A1 Recombinant antibody-enzyme fusion proteins |
11/12/1998 | CA2289046A1 Human g-protein coupled receptors |
11/12/1998 | CA2289025A1 Human serine protease precursor |
11/12/1998 | CA2288944A1 Enterococcus faecalis polynucleotides and polypeptides |
11/12/1998 | CA2288675A1 Human prohormone convertase 4 |
11/12/1998 | CA2288232A1 Immunotoxins directed against malignant cells |
11/12/1998 | CA2288017A1 Methods for eosinophil depletion and compositions therefor |
11/11/1998 | EP0877085A1 OspA protein of borrelia burgdorferi subgroups, encoding genes and vaccines |
11/11/1998 | EP0877083A1 A novel human G-protein coupled receptor (HCEPT09) |
11/11/1998 | EP0877032A1 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
11/11/1998 | EP0877030A2 EPO primary response gene 1,(EPRG1) |
11/11/1998 | EP0876616A2 Reagents for measuring lead levels via the quantification of porphobilinogen |
11/11/1998 | EP0876612A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
11/11/1998 | EP0876509A1 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
11/11/1998 | EP0876507A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2C$g(a) - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
11/11/1998 | EP0876491A1 A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 AND ITS ASSOCIATION WITH minK |
11/11/1998 | EP0876487A1 Mammalian cx 3?c chemokine genes |
11/11/1998 | EP0876486A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
11/11/1998 | EP0876485A2 NOVEL CREBa ISOFORM |
11/11/1998 | EP0876483A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
11/11/1998 | EP0876482A1 Il-13 receptor polypeptide |
11/11/1998 | EP0876478A1 Monoclonal antibody to herpes simplex virus and cell line producing same |
11/11/1998 | EP0876396A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
11/11/1998 | EP0876385A1 Topiramate immunoassay, as well as analogs and antibodies |
11/11/1998 | EP0876157A1 Methods and compositions for passive immunotherapy |
11/11/1998 | EP0831908A4 Methods of increasing cd4+ cell numbers in hiv-infected individuals |
11/11/1998 | CN1198667A Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
11/10/1998 | US5834597 Treating disorders requiring immune suppression with fewer side effects |
11/10/1998 | US5834593 Genetic engineering of prion protein |
11/10/1998 | US5834591 Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin |
11/10/1998 | US5834589 Chimeric viral receptor polypeptides |
11/10/1998 | US5834429 Inhibiting binding of a hiv antigen to receptors on cells of mammals |
11/10/1998 | US5834425 Composite of lectin and epidermal growth factor domains, treatment of pathological leukocyte mediated inflammation |
11/10/1998 | US5834310 Mammalian muscle NAD: arginine ADP-ribosyltransferase |
11/10/1998 | US5834309 Altering and/or regulating programmed cell death, genetic engineering, codes, expression vectors |
11/10/1998 | US5834307 Recombinant polynucleotide which codes for a polypeptide from a cytomegalovirus glycoprotein; for vaccines, diagnosis |
11/10/1998 | US5834290 Skin disorders such as acne, xeroderma, hyperkeratotic conditions, callosities and keratosis pilaris; ichthyoses, psoriasis and eczemas; autoimmune pemphigus, acatholytic diseases, familiar pemphigus and darier's disease |
11/10/1998 | US5834285 Recombinant thermostable DNA polymerase from archaebacteria |
11/10/1998 | US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus |
11/10/1998 | US5834256 Novel retroviral packaging system, transfection in human cells |
11/10/1998 | US5834250 Replacement of segment of polypeptide; calibration |
11/10/1998 | US5834238 Human GTP binding protein |
11/10/1998 | US5834236 AATT repeat transcription enhancer element |
11/10/1998 | US5834234 Nucleotide sequence coding; diagnosis of degenerative disorders |